EA2185
OPEN TO ACCRUAL
Pancreatic Cyst Surveillance
EA2192
OPEN TO ACCRUAL
APOLLO: PII Adjuvant Olaparib vs Placebo for Resected Pancreatic Cancer with BRCA1/2 or PALB2
NCI10366
OPEN TO ACCRUAL
A Phase 1/Randomized Phase 2 Study of M3814 w/ Hypofractionated Radiotherapy for LAPC
NCI10464
OPEN TO ACCRUAL
Ph1 Olaparib in Combo with durvalumab & radiation following 1st line chemo locally adv unresec panc
UW24051
OPEN TO ACCRUAL
Phase 1/2 Basket Study of MK-2870 in GI Cancers
UW24098
OPEN TO ACCRUAL
Ph 1/2 Study to Evaluate Safety and Efficacy of Patritumab Deruxtecan in Gastrointestinal Cancers